Testosterone and PSA Dynamics in Benign Prostatic Hyperplasia and Prostate Cancer: Evidence from Patients at Lagos University Teaching Hospital, Nigeria
Chukwum J. Okafor, Bart I. Ifionu, Ufuoma Ohwo, Nkem F. Obianagha, Emmanuel I. Obeagu, Omobolanle Abioye Ogundahunsi, E. N Adejumo & Seyi Samson Enitan · Journal of Cancer and Tumor International · 2025
Introduction: Prostatic diseases, including prostate cancer (CAP) and benign prostatic hyperplasia (BPH), are prevalent pathologies in ageing men. While prostate-specific antigen (PSA) is a well-established diagnostic marker, the role of serum testosterone in distinguishing betwe...
Open access
Research Article
10.9734/jcti/2025/v15i4328